Internal Medicine, Cardiovascular Disease · North Little Rock, AR
NPI
1730130956
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
4000 Richards Road, Ste A
North Little Rock, AR, 72117
Phone (501) 758-3999
Groups this clinician bills Medicare through
Medicare paid, 2024
$185K
4,274 services
Medicare patients, 2024
1,239
Average age 76
Drug cost, 2024
$1.4M
15,080 prescriptions
Company payments, 2025
$1,175
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark A St.Pierre was code 99214 (office e&m - established), 1,146 times for 962 patients. In total Mark A St.Pierre billed 4,274 services in 40 codes, and Medicare paid $185K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-01-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,146 | 962 | $67.98 | $78K |
| 93010 Electrocardiogram | Office | 702 | 593 | $5.01 | $3,518 |
| 93000 Electrocardiogram | Office | 516 | 432 | $8.63 | $4,454 |
| 93306 Echocardiography (TTE/TEE) | Office | 324 | 317 | $75.58 | $24K |
| 99232 Hospital E&M - Subsequent | Facility | 260 | 105 | $57.11 | $15K |
| 93306 Echocardiography (TTE/TEE) | Facility | 183 | 174 | $49.14 | $8,994 |
| 99223 Hospital E&M - Initial | Facility | 133 | 121 | $125.04 | $17K |
| 99233 Hospital E&M - Subsequent | Facility | 130 | 118 | $85.50 | $11K |
| 93294 External Electrocardiographic Monitoring | Office | 100 | 69 | $20.62 | $2,062 |
| 93010 Electrocardiogram | Facility | 98 | 95 | $5.87 | $576 |
| 93018 Electrocardiogram | Office | 93 | 93 | $9.75 | $907 |
| 93016 Electrocardiogram | Office | 93 | 93 | $14.77 | $1,373 |
| 78452 Myocardial Perfusion Scan | Office | 93 | 93 | $53.60 | $4,985 |
| 93280 External Electrocardiographic Monitoring | Office | 70 | 57 | $23.38 | $1,637 |
| 99204 Office E&M - New | Office | 63 | 63 | $91.58 | $5,769 |
By year: 2022 $248K for 5,470 services; 2023 $206K for 4,659 services; 2024 $185K for 4,274 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark A St.Pierre prescribed most often to Medicare patients was Amlodipine Besylate, with 1,870 prescriptions and refills. In total Mark A St.Pierre wrote 15,080 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,870 | 5,173 | 592 | $11K |
| Metoprolol Tartrate Generic | 1,781 | 4,717 | 532 | $8,255 |
| Rosuvastatin Calcium Generic | 1,292 | 3,314 | 382 | $17K |
| Atenolol Generic | 1,161 | 3,200 | 357 | $9,456 |
| Losartan Potassium Generic | 1,075 | 2,842 | 350 | $8,871 |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 946 | 2,534 | 328 | $4,977 |
| Olmesartan Medoxomil Generic | 883 | 2,433 | 270 | $16K |
| Valsartan Generic | 665 | 1,748 | 202 | $16K |
| Eliquis Apixaban | 659 | 1,163 | 133 | $632K |
| Hydrochlorothiazide Generic | 585 | 1,588 | 201 | $2,719 |
| Doxazosin Mesylate Generic | 519 | 1,398 | 179 | $8,099 |
| Entresto Sacubitril/Valsartan | 449 | 823 | 93 | $493K |
| Furosemide Generic | 368 | 844 | 134 | $1,589 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 328 | 797 | 87 | $3,661 |
| Ezetimibe Generic | 285 | 684 | 94 | $8,662 |
Brand drugs: 1,340 claims; generic drugs: 13,740 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark A St.Pierre $1,175 ($1,175 in general payments such as food, travel and fees) from 15 companies. The largest payer was Pfizer Inc. with $221.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 15 | $221 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $176 |
| Boston Scientific Corporation BSX | 2 | $169 |
| Merck Sharp & Dohme LLC MRK | 7 | $120 |
| Medtronic, Inc. MDT | 4 | $114 |
| Actelion Pharmaceuticals US, Inc. JNJ | 4 | $67.94 |
| Innovation Technologies Inc | 2 | $62.99 |
| Alnylam Pharmaceuticals Inc. ALNY | 3 | $59.95 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $39.74 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $34.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.